The Valley Desk

NCT04988555 · Interventional trial

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Acute, Multiple Myeloma, Myelodysplastic Syndromes

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov